• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVD

AVADA GROUP LIMITED - News & Media

0.00% ! 24.5¢
Market Cap $20.80M  !
Industrials Engineering & Construction
Add to My Watchlist

AVADA Group Limited is an Australia-based integrated traffic management provider, with... AVADA Group Limited is an Australia-based integrated traffic management provider, with operations throughout Queensland, New South Wales, Victoria and New Zealand servicing public and private sector clients. The Company operates through four segments: Queensland Traffic Management, New South Wales Traffic Management, Victoria Traffic Management, and New Zealand Traffic Management. Queensland Traffic Management contains entities which operate in the Queensland geography. New South Wales Traffic Management contains entities which operate in the New South Wales geography. Victoria Traffic Management contains entities which operate in the Victorian geography. New Zealand Traffic Management contains entities which operate in the New Zealand geography. Its businesses include Verifact Traffic, A2O Traffic Solutions, D&D Traffic Management, Platinum Traffic Services, Traffic Marshal, Construct Traffic, TRAFFIC MANAGEMENT PEOPLE (TMP) and Linemark Traffic Control.More

No News & Media currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
24.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.80M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1154 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 6800 1
View Market Depth
Last trade - 16.12pm 22/05/2025 (20 minute delay) ?
AVD (ASX) Chart

Top Stories

An RBA cut was locked in. Beijing’s identical Tuesday cut spotlights larger macro forces

An RBA cut was basically guaranteed. But Beijing’s identical Tuesday move spotlights larger macro forces After seeing countries...
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...
Raiden snaps up 75% of Vuzel gold project in Bulgaria as lithium days put to rest Raiden Resources (ASX:RDN) has all but formally pivoted away from lithium with its move to 75% ownership of the Vuzel gold...
Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
Long dormant Provaris, building a hydrogen tanker, eyes new market: CO2 storage Provaris Ltd (ASX:PV1), a decidedly unique ASX stock – it's attempting to build a world first hydrogen storage shipping tanker – has made...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.